Changeflow GovPing Healthcare & Life Sciences Phase 4 Opioid Use Disorder Trial in Vancouver,...
Routine Notice Added Final

Phase 4 Opioid Use Disorder Trial in Vancouver, Canada

Favicon for clinicaltrials.gov ClinicalTrials.gov - Phase 4 Trials
Detected
Email

Summary

ClinicalTrials.gov has registered a Phase 4 clinical trial (NCT07546396) investigating a treatment for opioid use disorder, with the trial site located in Vancouver, Canada. The registration provides a structured card-format summary of the trial including its phase classification, therapeutic area, and geographic location. This entry represents the current indexed record in the ClinicalTrials.gov database as of the posted update date.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 10 changes logged to date.

What changed

ClinicalTrials.gov published a card-format registry entry for a Phase 4 clinical trial focused on opioid use disorder, conducted in Vancouver, Canada. The entry appears in the Phase 4 trial filter results, sorted by most recent update. No substantive trial design, enrollment criteria, or intervention details are present in the displayed source content. Affected parties interested in this trial—including clinical investigators, research institutions, and healthcare providers—should follow the provided URL to access the full trial record including eligibility criteria, interventions, and contact information.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 4 Trials

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical trial registration Drug trial conduct
Geographic scope
California US-CA

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!